Key result
Non-alcoholic fatty liver disease is strongly associated with an increased risk of extra-hepatic diseases including type 2 diabetes, cardiovascular disease, and chronic kidney disease.
Design
Review
Authors
Loading...
May support enhanced screening for T2D, CVD, and CKD in NAFLD; leaves open causal impact on outcomes.
NAFLD is an emerging risk factor for cardiometabolic and renal diseases, emphasizing the need for multidisciplinary screening and management in affected patients.
Han et al. (2017) conducted a review in Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic fatty liver disease (NAFLD) vs. Absence of NAFLD was evaluated. Non-alcoholic fatty liver disease is strongly associated with an increased risk of extra-hepatic diseases including type 2 diabetes, cardiovascular disease, and chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: